Nurse Practitioner, Psychiatric/Mental Health · Mount Desert, ME
NPI
1861770166
Since 2011
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1049 Main Street, Unit 2s
Mount Desert, ME, 04660
Phone (207) 244-4111
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,698
154 services
Medicare patients, 2024
18
Average age 51
Drug cost, 2024
$197K
1,805 prescriptions
Company payments, 2025
$17.02
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kati M Derevere was code 99214 (office e&m - established), 64 times for 11 patients. In total Kati M Derevere billed 154 services in 4 codes, and Medicare paid $8,698.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 64 | 11 | $71.62 | $4,583 |
| 99443 Telephone Services | Office | 56 | 12 | $27.14 | $1,520 |
| 99215 Office E&M - Established | Office | 22 | 14 | $92.77 | $2,041 |
By year: 2022 $12K for 160 services; 2023 $9,198 for 151 services; 2024 $8,698 for 154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kati M Derevere prescribed most often to Medicare patients was Methylphenidate Hcl, with 172 prescriptions and refills. In total Kati M Derevere wrote 1,805 Medicare prescriptions that cost $197K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methylphenidate Hcl Generic | 172 | 180 | 13 | $7,088 |
| Clonazepam Generic | 167 | 167 | 15 | $1,214 |
| Alprazolam Generic | 90 | 90 | Under 11 | $612 |
| Trazodone Hcl Generic | 82 | 109 | 12 | $373 |
| Lamotrigine Generic | 74 | 139 | Under 11 | $609 |
| Trintellix Vortioxetine Hydrobromide | 68 | 70 | Under 11 | $33K |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 62 | 62 | Under 11 | $4,630 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 62 | 62 | Under 11 | $1,667 |
| Bupropion Xl Bupropion Hcl | 60 | 98 | Under 11 | $1,806 |
| Lorazepam Generic | 58 | 58 | Under 11 | $419 |
| Aripiprazole Generic | 46 | 57 | Under 11 | $8,376 |
| Prazosin Hcl Generic | 37 | 55 | Under 11 | $541 |
| Lurasidone Hcl Generic | 35 | 35 | Under 11 | $9,948 |
| Escitalopram Oxalate Generic | 35 | 47 | Under 11 | $154 |
| Risperidone Generic | 35 | 35 | Under 11 | $302 |
Brand drugs: 179 claims; generic drugs: 1,626 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kati M Derevere $17.02 ($17.02 in general payments such as food, travel and fees) from 1 company. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $17.02.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $17.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.